DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update ...Middle East

News by : (PR Newswire) -
- FDA Granted Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - Held Type B Meeting with FDA to Discuss Phase 3 Clinical Trial Design - Seeking to Initiate Phase 3 Trial in 2024 with Topline Results Expected in 2H 2026 - Webcast of Earnings Call Today,...

Hence then, the article about durect corporation reports second quarter 2024 financial results and business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار